The increasing frequency of multidrug-resistant bacteria and a recent slowing in the
development of new antimicrobial agents place mankind in a state of emergency with regard …

The emergence of antimicrobial-resistant infections is still a major concern for public health
worldwide. The number of pathogenic microorganisms capable of resisting common …

The evolution of pathogenic bacteria has allowed many microbes to develop resistance
mechanisms against conventional antibiotics, leading to the search for new therapeutic …

Antimicrobial peptides (AMPs) discovered about 30 years ago are responsible for part of the
innate immunity of animals and plants, and almost 3000 peptides have been reported so far …

The increasing appearance of multidrug-resistant pathogens has created an urgent need for
suitable alternatives to current antibiotics. Antimicrobial peptides (AMPs), which act as …

Antibiotics are essential drugs used to treat pathogenic bacteria, but their prolonged use
contributes to the development and spread of drug-resistant microorganisms. Antibiotic …

Antimicrobial peptides (AMPs) are short peptidic molecules produced by most living
creatures. They help unicellular organisms to successfully compete for nutrients with other …

For over fifty years, people have used antibiotics to treat illnesses caused by pathogens.
However, the excessive and inappropriate use of these antibiotics in clinical treatment of …

The concept of antimicrobial peptides (AMPs) as potent pharmaceuticals is firmly
established in the literature, and most research articles on this topic conclude by stating that …

Antibiotics have been among the most successful classes of therapeutics and have enabled
many of modern medicine's greatest advances. However, antibiotic-resistant bacteria are …